My Quote Request
No products added yet
6505-01-306-5084
20 Products
SPECTAZOLE CREAM
ECONAZOLE NITRATE CREAM
NSN, MFG P/N
6505013065084
NSN
6505-01-306-5084
SPECTAZOLE CREAM
ECONAZOLE NITRATE CREAM
NSN, MFG P/N
6505013065084
NSN
6505-01-306-5084
MFG
ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ECONAZOLE NITRATE CREAM 15GM COLLAPSIBLE TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: 1.000 PCT W/W ECONZAOLE NITRATE
Related Searches:
NDC59772-5589-02
CHOLESTYRAMINE FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505013060344
NSN
6505-01-306-0344
NDC59772-5589-02
CHOLESTYRAMINE FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505013060344
NSN
6505-01-306-0344
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 GRAMS CHOLESTYRAMINE RESIN, ANHYDROUS EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHOLESTYRAMINE FOR ORAL SUSPENSION USP 210GM CAN
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 210.000 GRAMS
PRIMARY CONTAINER TYPE: CAN
SPECIAL FEATURES: 42 DOSES PER CAN TO CONTAIN A SCOOP TO MEASURE 5 GRAMS,EACH 5 GRAMS (DOSE) SCOOP CONTAINS 4 GRAMS CHOLESTRYAMINE RESIN,AND HYDROUS; 16.8 MG PHENYLALANINE NUTRASWEET AND 3 MG SUCROSE; CAN HAS A PLASTIC SNAP LID TO PROVIDE A SEAL FOR THE TOP OF THE CAN UPON
~1: OPENING
Related Searches:
QUESTRAN LIGHT
CHOLESTYRAMINE FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505013060344
NSN
6505-01-306-0344
QUESTRAN LIGHT
CHOLESTYRAMINE FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505013060344
NSN
6505-01-306-0344
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 GRAMS CHOLESTYRAMINE RESIN, ANHYDROUS EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHOLESTYRAMINE FOR ORAL SUSPENSION USP 210GM CAN
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 210.000 GRAMS
PRIMARY CONTAINER TYPE: CAN
SPECIAL FEATURES: 42 DOSES PER CAN TO CONTAIN A SCOOP TO MEASURE 5 GRAMS,EACH 5 GRAMS (DOSE) SCOOP CONTAINS 4 GRAMS CHOLESTRYAMINE RESIN,AND HYDROUS; 16.8 MG PHENYLALANINE NUTRASWEET AND 3 MG SUCROSE; CAN HAS A PLASTIC SNAP LID TO PROVIDE A SEAL FOR THE TOP OF THE CAN UPON
~1: OPENING
Related Searches:
EULEXIN
FLUTAMIDE CAPSULES,USP
NSN, MFG P/N
6505013061728
NSN
6505-01-306-1728
MFG
SCHERING-PLOUGH CORPORATION
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.45 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 9.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.011 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.25 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS FLUTAMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
EULEXIN CAPSULES
FLUTAMIDE CAPSULES,USP
NSN, MFG P/N
6505013061728
NSN
6505-01-306-1728
EULEXIN CAPSULES
FLUTAMIDE CAPSULES,USP
NSN, MFG P/N
6505013061728
NSN
6505-01-306-1728
MFG
SCHERING-PLOUGH CORPORATION
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.45 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 9.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.011 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.25 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS FLUTAMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00085-0525-04
FLUTAMIDE CAPSULES,USP
NSN, MFG P/N
6505013061728
NSN
6505-01-306-1728
NDC00085-0525-04
FLUTAMIDE CAPSULES,USP
NSN, MFG P/N
6505013061728
NSN
6505-01-306-1728
MFG
SCHERING-PLOUGH CORPORATION
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.45 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 36
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 9.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.011 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.25 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS FLUTAMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00591-5346-04
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505013062707
NSN
6505-01-306-2707
NDC00591-5346-04
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505013062707
NSN
6505-01-306-2707
MFG
DANBURY PHARMACAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
A93A050
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013062708
NSN
6505-01-306-2708
A93A050
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013062708
NSN
6505-01-306-2708
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
K-DUR 20
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013062708
NSN
6505-01-306-2708
K-DUR 20
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013062708
NSN
6505-01-306-2708
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00085-0787-10
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013062708
NSN
6505-01-306-2708
NDC00085-0787-10
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505013062708
NSN
6505-01-306-2708
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
13320
DESIPRAMINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013064369
NSN
6505-01-306-4369
13320
DESIPRAMINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013064369
NSN
6505-01-306-4369
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DESIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FILM COATED; ROUND
Related Searches:
NDC00182-1848-01
DESIPRAMINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013064369
NSN
6505-01-306-4369
NDC00182-1848-01
DESIPRAMINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013064369
NSN
6505-01-306-4369
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS DESIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FILM COATED; ROUND
Related Searches:
1105060
ASPIRIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013064370
NSN
6505-01-306-4370
1105060
ASPIRIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013064370
NSN
6505-01-306-4370
MFG
MAJOR CROWN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 81.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FLAVORED
Related Searches:
NDC00904-4040-80
ASPIRIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013064370
NSN
6505-01-306-4370
NDC00904-4040-80
ASPIRIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013064370
NSN
6505-01-306-4370
MFG
MAJOR CROWN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 81.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FLAVORED
Related Searches:
HEALON
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505013064748
NSN
6505-01-306-4748
MFG
ADVANCED MEDICAL OPTICS INC. DBA A M O
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: INTRAOCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM HYALURONATE INJECTION 10MG/ML 0.85ML SYRINGE
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 0.850 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
Related Searches:
NDC00016-0310-55
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505013064748
NSN
6505-01-306-4748
NDC00016-0310-55
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505013064748
NSN
6505-01-306-4748
MFG
PHARMACIA & UPJOHN
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: INTRAOCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM HYALURONATE INJECTION 10MG/ML 0.85ML SYRINGE
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 0.850 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
Related Searches:
NDC00016-0310-85
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505013064748
NSN
6505-01-306-4748
NDC00016-0310-85
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505013064748
NSN
6505-01-306-4748
MFG
CARDINAL HEALTH 100 INC DBA BINDLEY WESTERN TENNESSEE DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: INTRAOCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM HYALURONATE INJECTION 10MG/ML 0.85ML SYRINGE
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 0.850 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
Related Searches:
NDC00008-0326-06
CODEINE SULFATE TABLETS,USP
NSN, MFG P/N
6505013065080
NSN
6505-01-306-5080
NDC00008-0326-06
CODEINE SULFATE TABLETS,USP
NSN, MFG P/N
6505013065080
NSN
6505-01-306-5080
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS CODEINE SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CODEINE SULFATE TABLETS USP 30MG 250S
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP, REVERSE NUMBERED
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE II
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00062-5460-02
ECONAZOLE NITRATE CREAM
NSN, MFG P/N
6505013065084
NSN
6505-01-306-5084
NDC00062-5460-02
ECONAZOLE NITRATE CREAM
NSN, MFG P/N
6505013065084
NSN
6505-01-306-5084
MFG
ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ECONAZOLE NITRATE CREAM 15GM COLLAPSIBLE TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: 1.000 PCT W/W ECONZAOLE NITRATE
Related Searches:
SPECTAZOLE
ECONAZOLE NITRATE CREAM
NSN, MFG P/N
6505013065084
NSN
6505-01-306-5084
MFG
ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ECONAZOLE NITRATE CREAM 15GM COLLAPSIBLE TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: 1.000 PCT W/W ECONZAOLE NITRATE
